In vivo effects of deltamethrin on dopamine neurochemistry and the role of augmented neurotransmitter release

Pesticide Biochemistry and Physiology

Volumn 65, Issue 3, 1999, Pages 160-168

  Kirby, Michael L ^a   Castagnoli, Kay ^a   Bloomquist, Jeffrey R ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Deltamethrin; Dopami ne; Glutamate; MPTP; Parkinson's disease; Serotonin

Indexed keywords

PARKINSONIA;

EID: 0032805772     PISSN: 00483575     EISSN: None     Source Type: Journal    
DOI: 10.1006/pest.1999.2440     Document Type: Article

References (41)

1. W. C. Bowman and M. J. Rand, "Textbook of Pharmacology," 2nd ed., p. 18. 17, Blackwell Sci., Oxford, 1980.
2. M. B. Streifler, Sensory and musculo-skeletal dysfunction in Parkinson's disease - Premonitory and permanent, in "Early Diagnosis and Preventative Therapy in Parkinson's Disease" (A. Carlsson, P. Reiderer, and H. Beckmann, Eds.) Springer-Verlag, New York, 1989.
3. O. Hornykiewicz and S. Kish, Biochemical pathophysiology of Parkinson's disease, in "Parkinson's Disease" (M. D. Yahr and K. J. Bergmann, Eds.), Raven Press, New York, 1986.
4. J. M. Fearnley and A. J. Lees, Ageing and Parkinson's disease: Substantia nigra regional selectivity, Brain 114, 2283 (1991).
5. P. Jenner, H. V. A. Schapira, and C. D. Marsden, New insights into the cause of Parkinson's disease, Neurology 42, 2241 (1992).
6. M. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W. G. Johnson, A. M. Lazzarini, R. C. Duvoisin, G. Di Lorio, L. I. Golbe, and R. L. Nussbaum, Mutation in the α-synuclein gene identified in families with Parkinson's disease, Science 276, 2045 (1997).
7. D. E. Lilienfield, E. Chan, J. Ehland, J. Godbold, P. J. Landrigan, C. Marsh, and D. P. Perl, Two decades of increasing mortality from Parkinson's disease among the US elderly, Arch. Neurol 47, 731 (1991).
8. L. Morgante, W. Rocca, A. Di Rosa, P. De Dominico, F. Grigoletto, F. Meneghini, A. Reggio, G. Savettieri, M. Castiglione, F. Patti, and R. Di Perri, Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities, Neurology 42, 1901 (1992).
9. A. Chio, C. Magnani, G. Tolardo, and D. Schiffer, Parkinson's disease mortality in Italy, 1951 through 1987. Analysis of an increasing trend, Arch. Neurol. 50, 149 (1993).
10. B. Rybicki, C. Johnson, J. Uman, and J. Gorell, Parkinson's disease mortality and the industrial use of heavy metals in Michigan, Mov. Disord. 8, 87 (1993).
11. G. Wong, C. Gray, R. Hassanein, and W. Koller, Environmental risk factors in siblings with Parkinson's disease, Arch. Neurol. 48, 287 (1991).
12. E. Granieri, M. Carreras, I. Casetta, V. Govoni, M. Tola, E. Paolino, E. Monetti, and P. Debstiani, Parkinson's disease in Ferrara, Italy, 1967 through 1987, Arch. Neurol. 48, 854 (1991).
13. P. Butterfield, B. Valanis, P. Spencer, C. Lindeman, and J. Nutt, Environmental antecedents of young-onset Parkinson's disease, Neurology 43, 1150 (1993).
14. K. Semchuk, E. Love, and R. Lee, Parkinson's disease and exposure to argicultural work and pesticide chemicals, Neurology 42, 1328 (1992).
15. K. Semchuk, E. Love, and R. Lee, Parkinson's disease -A test of the multifactorial etiologic hypothesis, Neurology 43, 1173 (1993).
16. L. Fleming, J. Mann, J. Bean, T. Briggle, and J. Sanchez-Ramos, Parkinson's disease and brain levels of organochlorine pesticides, Ann. NeurOl. 36, 100 (1994).
17. J. R. Bloomquist, Neuroreceptor mechanisms in pyrethroid mode of action and resistance, Rev. Pestic. Toxicol. 2, 185 (1993).
18. R. E Heikkila and P. K. Sonsalla, The MPTP-treated mouse as a model of parkinsonism: How good is it? Neurochem. Int. 20, 299S (1992).
19. K. F. Tipton and T. P. Singer, Advances in our understanding of the mechanism of the neurotoxicity of MPTP and related compounds, J. Neurochem. 61, 1191 (1993).
20. J. R. Bloomquist, M. L. Kirby, K. Castagnoli, and G. W. Miller, Effects of Heptachlor Exposure on Neurochemical Biomarkers of Parkinsonism, in "Neurotox '98: Progress in Neuropharmacology And Neurotoxicology of Pesticides and Drugs" (D. Beadle, Ed.), pp. 195-203, Society of Chemical Industry, 1999.
21. M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding, Anal. Biochem. 72, 248 (1976).
22. B. K. Krueger, Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus, J. Neurochem. 55, 260 (1990).
23. L. Hall, S. Murray, K. Castagnoli, and N. Castagnoli, Studies on 1,2,3,6-tetrahydropyridine derivatives as potential monoamine oxidase inactivalors, Chem. Res. Toxicol. 5, 625 (1992).
24. J. R. Bloomquist and D. M. Soderlund, Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxicant, MoL. Pharmacol. 33, 543 (1988).
25. M. Gerlach, P. Riederer, H. Przuntek, and M. Youdim, MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease, Eur. J. Pharmacol. 208, 273 (1991).
26. J. Doherty, N. Morii, T. Hiromori, and J-I. Ohnishi, Pyrethroids and the striatal dopaminergic system in vivo, Comp. Biochem. Physiol. 91C, 371 (1988).
27. S. Izenwasser and B. Cox, Repeated and chronic cocaine treatments have differential effects on serotonin and dopamine uptake in rat striatum and nucleus accumbens, in "Problems of Drug Dependence 1991" (L Harris, Ed.), Natl. Inst. Drug Abuse Res. Mono. 119, 241 (1992).
28. G. W. Miller, M. L. Kirby, A. I. Levey, and J. R. Bloomquist, Heptachlor alters expression and function of dopamine transporters, Neurotoxicology 20, 631 (1999).
29. L. Miller, J. Koff, and L. Shuster, Chronic cocaine administration is associated with behavioral sensitization and dopamine transporter upregulation, Soc. Neurosci. Abstr. 19, 1498 (1993).
30. J. Javitch, R. D'Amato, S. Strittmatter, and S. Snyder, Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. USA 82, 2173 (1985).
31. M. Yoshida, M. Ogawa, K. Suzuki, and T. Nagatsu, Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogs, Adv. Neurol. 60, 207 (1993).
32. M. Collins, E. Neafsey, and K. Matsubara, β-Carbolines: Metabolism and neurotoxicity, Biogenic Amines 12, 171 (1996).
33. R. Husain, V. Adhami, and P. Seth, Behavioral, neurochemical, and neuromorphological effects of delta-methrin in adult rats, J. Toxicol. Environ. Health 48, 515 (1996).
34. G. V. Rao and K. S. J. Rao, Inhibition of monoamine oxidase-A of rat brain by pyrethroids-an in vitro kinetic study, Mol. Cell. Biochem. 124, 107 (1993).
35. J. T. Eells and M. L. Dubocovich, Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices, J. Pharmacol. Exp. Therap. 246, 514 (1988).
36. J. W. Olney, Excitatory transmitter neurotoxicity, Neurobiol. Aging 15, 259 (1994).
37. F. Filloux and J. Townsend, Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection, Exp. Neurol. 119, 79 (1993).
38. S. Johnson, V. Seutin, and R.A. North, Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump, Science 258, 665 (1992).
39. I. Marey-Semper, M. Gelman, and M. Levi-Strauss, The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons of the substantia nigra, Eur. J. Neurosci. 5, 1029 (1993).
40. D. E. Ray, An EEG investigation of decamethrin-induced choreoathetosis in the rat, Exp. Brain Res. 38, 221 (1980).
41. D. E. Ray, Changes in brain blood flow associated with deltamethrin-induced choreoathetosis in the rat, Exp. Brain Res. 45, 269 (1982).